Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma. [electronic resource]
Producer: 20190909Description: 2910 p. digitalISSN:- 2041-1723
- Animals
- Antigens, Surface -- genetics
- Ataxia Telangiectasia Mutated Proteins -- genetics
- Cell Cycle Proteins -- genetics
- Cyclin-Dependent Kinases -- genetics
- Drug Resistance, Neoplasm
- Female
- Glioblastoma -- drug therapy
- Homologous Recombination
- Humans
- Mice
- Mice, SCID
- N-Myc Proto-Oncogene Protein -- genetics
- Neoplastic Stem Cells -- metabolism
- Poly (ADP-Ribose) Polymerase-1 -- genetics
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Protein Binding
- Proto-Oncogene Proteins c-myc -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.